Hospital Civil De Guadalajara
Clinical trials sponsored by Hospital Civil De Guadalajara, explained in plain language.
-
Turmeric compound tested as sepsis treatment in new trial
Disease control Not yet recruitingThis study tests whether curcumin, a natural compound found in turmeric, can help control the overwhelming immune response in critically ill patients with sepsis. Sepsis is a life-threatening condition where the body's reaction to infection damages its own organs. The trial will …
Phase: NA • Sponsor: Hospital Civil de Guadalajara • Aim: Disease control
Last updated May 11, 2026 20:49 UTC
-
Can a tiny dose of apixaban save dialysis catheters?
Disease control Not yet recruitingThis study tests whether adding a low dose of the blood thinner apixaban to the usual heparin lock can help prevent dialysis catheters from failing. About 54 adults with end-stage kidney disease who have a new tunneled catheter will take apixaban or a placebo for up to 24 months.…
Phase: PHASE4 • Sponsor: Hospital Civil de Guadalajara • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Common antibiotic may shield kidney patients from Post-Hospital infections
Prevention Not yet recruitingThis study tests whether a low-dose antibiotic (TMP/SMX) can prevent infections in adults who recently had acute kidney injury and are leaving the hospital. About 120 participants will receive either the antibiotic or a placebo for 90 days. Researchers will track infections, hosp…
Phase: PHASE2 • Sponsor: Hospital Civil de Guadalajara • Aim: Prevention
Last updated May 17, 2026 04:41 UTC
-
Lung rehab may strengthen breathing muscle in scarred lungs
Symptom relief Not yet recruitingThis study looks at whether an 8-week pulmonary rehabilitation program can improve diaphragm function, exercise ability, and quality of life in 20 adults with interstitial lung disease (scarred and stiff lungs). Participants will do exercises and learn breathing techniques. The g…
Phase: NA • Sponsor: Hospital Civil de Guadalajara • Aim: Symptom relief
Last updated May 11, 2026 20:41 UTC